Here's What Key Metrics Tell Us About Hims & Hers Health (HIMS) Q1 Earnings

Hims & Hers Health, Inc. (HIMS) reported $586.01 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 110.7%. EPS of $0.20 for the same period compares to $0.05 a year ago.The reported revenue represents a surprise of +8.91% over the Zacks Consensus Estimate of $538.1 million. With the consensus EPS estimate being $0.12, the EPS surprise was +66.67%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Hims & Hers Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Monthly Online Revenue per Average Subscriber: $84 versus the two-analyst average estimate of $76.47. Subscribers (end of period): 2.37 million versus the two-analyst average estimate of 2.31 million. Revenue- Wholesale: $9.65 million versus the five-analyst average estimate of $11.06 million. Revenue- Online: $576.36 million compared to the $527.37 million average estimate based on five analysts. View all Key Company Metrics for Hims & Hers Health here>>>Shares of Hims & Hers Health have returned +57.1% over the past month versus the Zacks S&P 500 composite's +0.4% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Hims & Hers Health, Inc. (HIMS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks